NTZ submitted to FDA for cryptosporidiosis. Food and Drug Administration.
James
J S
JS
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000975:Antioxidants / Q000627:therapeutic use*; D003457:Cryptosporidiosis / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D009574:Nitro Compounds; D013844:Thiazoles / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000975:Antioxidants; D009574:Nitro Compounds; D013844:Thiazoles; C041747:nitazoxanide